Overview
Post the onset of COVID-19 pandemic, there has been a decline in number of patients visiting laboratories for sample collection and testing. Owing to the risk of infection associated with such places, several patients postponed their routine tests and medical checkups, in order to avoid the spread of the disease. In fact, an average decline of approximately 40% in phlebotomy appointments was reported by various laboratories across the globe. The aforementioned concerns have encouraged stakeholders to develop novel devices and technologies that can enable patients to self-collect their blood samples at-home, to monitor their health remotely. Over 80% of the self-blood collecting devices that we came across during our research have already received marketing approval. In 2021, TAP® II and Tasso-M20 self-blood collecting devices received the CE mark from the European Commission. Further, recently, Symbiotica received emergency use authorization by the USFDA for its proprietary at-home COVID-19 serology test kit, which has been demonstrated to be capable of detecting the presence of SARS-CoV-2 using dried blood spot samples.
The at-home blood collection and micro sampling devices market is fragmented, featuring a mix of start-ups/small companies and mid-sized firms. Interestingly, over 40% of the start-ups engaged in this domain have been established since 2014. Further, large firms are actively acquiring small industry players in order to either consolidate their existing capabilities or enter this niche domain. Consequently, there has been a significant increase in the partnership activity related to at-home blood collection devices, over the past few years. In addition, both public and private investors have invested a sum of more than USD 640 million in this domain, since 2014. Given the rising adoption and preference for at-home and self-blood collection approaches, coupled to the ongoing efforts of device developers and manufacturers to further expand their respective offerings, we believe that the at-home blood collection and micro sampling devices market is likely to witness significant growth in the foreseen future.
Scope of the Report
The “At-Home Blood Collection and Micro Sampling Devices Market by Type of Blood Sample State (Dried and Liquid), Method of Sample Collection (Fingerstick and Push-Button Method), Device Usage (Single-use and Reusable), Area of Application (Diagnostics, Research, Therapeutics and Others), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and MENA) - Industry Trends and Global Forecasts, 2021-2030” report features an extensive study of the current market landscape and the likely adoption of at-home self-blood collection and micro sampling devices, over the next decade. The study features a detailed analysis of the key drivers and trends related to this evolving domain.
Amongst other elements, the report features:
- A detailed overview of the current market landscape of at-home self-blood collection and micro sampling devices, along with information on several relevant parameters, such as device class (class I and class II), current status of development (marketed, emergency use authorization, available for investigational use only and under development), regulatory approvals/certifications received (CE Mark, USFDA, TGA, KFDA and Health Canada), type of technology, device usage (single-use and reusable), type of sample (whole capillary blood, plasma and serum), blood sample state (dried and liquid), volume of sample collected, puncture site (fingertip, upper arm, heel and toe), method of sample collection (fingerstick and push-button method), storage temperature and application area. In addition, it presents details of the companies engaged in the development of at-home blood collection and micro sampling devices, along with information on their respective year of establishment, company size, location of headquarters and most active players (in terms of number of devices).
- Elaborate profiles of key players engaged in this domain. Each company profile features a brief overview of the company, along with information on year of establishment, location of headquarters, number of employees, key executives, product portfolio, recent developments and an informed future outlook.
- An in-depth product competitiveness analysis of at-home blood collection and micro sampling devices based on several relevant parameters, such as supplier power (in terms of expertise of the companies) and key product-related specifications (device class, current status of development, device usage, type of sample, application areas and regulatory approvals/certifications).
- A detailed analysis of various patents that have been filed/granted within this domain, since 2015. The analysis assesses several relevant parameters associated with the patents, including type of patent (granted patents and patent applications), publication year, regional applicability, CPC symbols, emerging focus areas, most active players (in terms of the number of patents filed/granted), and patent valuation.
- An analysis of the recent partnerships inked between various players engaged in this domain, during the period 2014-2021, based on several relevant parameters, such as year of partnership, type of partnership model adopted, focus area, therapeutic area and regional distribution.
- A detailed analysis of various investments made by players engaged in this domain, based on several relevant parameters, such as year of investment, number of funding instances, amount invested and type of funding (grant, debt, seed, venture capital, initial public offering (IPO) and other equity), along with information on the most active players (in terms of number of funding instances and amount raised), most active investors (in terms of number of funding instances), geographical distribution, purpose of investment and application area.
- An insightful analysis highlighting the cost saving potential associated with at-home self-blood collection and micro sampling devices, taking into consideration several relevant parameters.
One of the key objectives of the report was to evaluate the current opportunity and future potential of at-home self-blood collection and micro sampling devices market, over the coming decade. We have also provided an informed estimate on the likely evolution of the market in the short to mid-term and long term, over the period 2021-2030. Additionally, the report features the likely distribution of the current and forecasted opportunity across [A] blood sample state (dried and liquid), [B] method of sample collection (fingerstick and push-button method), [C] device usage (single-use and reusable), [D] area of application (diagnostics, research, therapeutics and others), and [E] key geographical regions (North America, Europe, Asia-Pacific, Latin America, and MENA). In order to account for future uncertainties and add robustness to our forecast model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Key Questions Answered
- Who are the key players engaged in the development of at-home self-blood collection and micro sampling devices?
- Which are the most popular at-home self-blood collection and micro sampling devices available in the market?
- What types of partnership models are commonly being adopted by stakeholders in this industry?
- Who are the key investors that have actively made investments in this domain?
- How is the intellectual property landscape in this field likely to evolve in the foreseen future?
- What is relative competitiveness of different at-home blood collection and micro sampling devices?
- How much cost can be saved by using at-home blood collection and micro sampling devices?
- How is the current and future market opportunity likely to be distributed across key market segments?
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of At-Home Blood Collection and Micro Sampling Devices
3.3. Applications of Blood Sampling and Testing
3.3.1. Complete Blood Count
3.3.2. Basic Metabolic Panel
3.3.3. Lipoprotein Panel
3.4. Types of Blood Sampling
3.4.1. Dried Blood Sampling
3.4.2. Wet Blood Sampling
3.5. Benefits of At-Home Blood Collection
3.6. Methods Used for At-Home Blood Collection
3.6.1. Fingerstick Method
3.6.2. Press Button Method
3.6.3. Heel-stick Method
3.7. Types of At-Home Blood Collection and Micro Sampling Devices
3.7.1. Dried Blood Spot Collection Kits
3.7.2. Microtainer Tubes
3.8. Future Perspectives
4. MARKET OVERVIEW
4.1. Chapter Overview
4.2. At-Home Blood Collection and Micro Sampling Devices: Overall Market Landscape
4.2.1. Analysis by Device Class
4.2.2. Analysis by Current Status of Development
4.2.3. Analysis by Regulatory Approvals / Certifications Received
4.2.4. Analysis by Type of Technology
4.2.5. Analysis by Device Usage
4.2.6 Analysis by Type of Sample
4.2.7. Analysis by Blood Sample State
4.2.8. Analysis by Volume of Sample Collected
4.2.9. Analysis by Puncture Site
4.2.10. Analysis by Method of Sample Collection
4.2.11. Analysis by Storage Temperature
4.2.12. Analysis by Application Area
4.3. At-Home Blood Collection and Micro Sampling Devices: List of Developers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Geography
4.3.4. Analysis by Year of Establishment, Company Size and Location of Headquarters
4.4. Most Active Players: Analysis by Number of Products
5. PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Input Parameters
5.3. Methodology
5.3.1. Product Competitiveness Analysis: North America
5.3.2. Product Competitiveness Analysis: Europe
5.3.3. Product Competitiveness Analysis: Asia-Pacific
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. EUROIMMUN
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Everlywell
6.3.1. Company Overview
6.3.2. Product Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Labcorp
6.4.1. Company Overview
6.4.2. Product Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. Labonovum
6.5.1. Company Overview
6.5.2. Product Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. Lameditech
6.6.1. Company Overview
6.6.2. Product Portfolio
6.6.3. Recent Developments and Future Outlook
6.7. Quest Diagnostics
6.7.1. Company Overview
6.7.2. Product Portfolio
6.7.3. Recent Developments and Future Outlook
6.8. Spot On Sciences
6.8.1. Company Overview
6.8.2. Product Portfolio
6.8.3. Recent Developments and Future Outlook
6.9. Tasso
6.9.1. Company Overview
6.9.2. Product Portfolio
6.9.3. Recent Developments and Future Outlook
6.10. Weavr Health
6.10.1. Company Overview
6.10.2. Product Portfolio
6.10.3. Recent Developments and Future Outlook
6.11. YourBio Health
6.11.1. Company Overview
6.11.2. Product Portfolio
6.11.3. Recent Developments and Future Outlook
7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. At-Home Blood Collection and Micro Sampling Devices: Patent Analysis
7.2.1. Scope and Methodology
7.2.2. Analysis by Publication Year
7.2.3. Analysis by Publication Year and Type of Patent
7.2.4. Analysis by Geography
7.2.5. Analysis by CPC Symbols
7.2.6. Analysis by Emerging Focus Area
7.2.7. Most Active Players: Analysis by Number of Patents
7.2.8. Patent Benchmarking Analysis
7.2.9. Patent Valuation Analysis
7.2.10. Overall Intellectual Property Portfolio: Analysis by Type of Organization
8. PARTNERSHIPS
8.1. Chapter Overview
8.2. Partnership Models
8.3. At-Home Blood Collection and Micro Sampling Devices: List of Partnerships
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Focus Area
8.3.5. Analysis by Year of Partnership and Focus Area
8.3.6. Analysis by Type of Partnership and Focus Area
8.3.7. Analysis by Therapeutic Area
8.3.8. Analysis by Region
8.3.8.1. Continent-wise Distribution
8.3.8.2. Intercontinental and Intracontinental Distribution
8.3.8.3. Country-wise Distribution
8.3.9. Most Active Players: Analysis by Number of Partnerships
9. FUNDING AND INVESTMENT ANALYSIS
9.1. Chapter Overview
9.2. Types of Funding
9.3. At-Home Blood Collection and Micro Sampling Devices: Funding and Investment Analysis
9.3.1. Analysis of Number of Funding Instances by Year
9.3.2. Analysis by Amount Invested
9.3.3. Analysis by Type of Funding
9.3.4. Analysis by Year and Type of Funding
9.3.5. Analysis of Amount Invested by Geography
9.3.6. Most Active Players: Analysis by Number of Funding Instances and Amount Invested
9.3.7. Key Investors: Analysis by Number of Funding Instances
9.3.8. Analysis by Purpose of Investment
9.3.9. Analysis by Application Area
9.4. Concluding Remarks
10. COST SAVING ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions
10.3. Methodology
10.4. Overall Cost Saving Potential of At-Home Blood Collection and Micro Sampling Devices
10.5. Concluding Remarks
11. MARKET FORECAST
11.1. Chapter Overview
11.2. Forecast Methodology and Assumptions
11.3. Global At-Home Blood Collection and Micro Sampling Devices Market, 2021-2030
11.3.1. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2030: Analysis by Blood Sample State
11.3.1.1. At-Home Blood Collection and Micro Sampling Devices Market for Dried Blood Samples, 2021-2030
11.3.1.2. At-Home Blood Collection and Micro Sampling Devices Market for Liquid Blood Samples, 2021-2030
11.3.2. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2030: Analysis by Method of Sample Collection
11.3.2.1. At-Home Blood Collection and Micro Sampling Devices Market for Fingerstick Method of Sample Collection, 2021-2030
11.3.2.2. At-Home Blood Collection and Micro Sampling Devices Market for Push-Button Method of Sample Collection, 2021-2030
11.3.3. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2030: Analysis by Device Usage
11.3.3.1. At-Home Blood Collection and Micro Sampling Devices Market for Single-use Devices, 2021-2030
11.3.3.2. At-Home Blood Collection and Micro Sampling Devices Market for Reusable Devices, 2021-2030
11.3.4. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2030: Analysis by Area of Application
11.3.4.1. At-Home Blood Collection and Micro Sampling Device Market for Diagnostics, 2021-2030
11.3.4.2. At-Home Blood Collection and Micro Sampling Device Market for Research, 2021-2030
11.3.4.3. At-Home Blood Collection and Micro Sampling Device Market for Therapeutics, 2021-2030
11.3.4.4. At-Home Blood Collection and Micro Sampling Device Market for Other Areas of Application, 2021-2030
11.3.5. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2030: Analysis by Region
11.3.5.1. At-Home Blood Collection and Micro Sampling Devices Market in North America, 2021-2030
11.3.5.2. At-Home Blood Collection and Micro Sampling Devices Market in Europe, 2021-2030
11.3.5.3. At-Home Blood Collection and Micro Sampling Devices Market in Asia-Pacific, 2021-2030
11.3.5.4. At-Home Blood Collection and Micro Sampling Devices Market in Latin America, 2021-2030
11.3.5.5. At-Home Blood Collection and Micro Sampling Devices Market in MENA, 2021-2030
12. CONCLUSION
13. EXECUTIVE INSIGHTS
13.1. Chapter Overview
13.2. Interview Transcript: Radhika Pawa, Business Development Manager, Lipomic Healthcare
14. APPENDIX I: TABULATED DATA
15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
List Of Figures
Figure 2.1 Executive Summary: Current Market Landscape
Figure 2.2 Executive Summary: Product Competitiveness Analysis
Figure 2.3 Executive Summary: Patent Analysis
Figure 2.4 Executive Summary: Partnerships and Collaborations
Figure 2.5 Executive Summary: Funding and Investment Analysis
Figure 2.6 Executive Summary: Cost Saving Analysis
Figure 2.7 Executive Summary: Market Sizing and Opportunity Analysis
Figure 3.1 Process of Sampling Dried Blood
Figure 4.1 At-Home Blood Collection and Micro Sampling Devices: Distribution by Device Class
Figure 4.2 At-Home Blood Collection and Micro Sampling Devices: Distribution by Current Status of Development
Figure 4.3 At-Home Blood Collection and Micro Sampling Devices: Distribution by Regulatory Approvals / Certifications Received
Figure 4.4 At-Home Blood Collection and Micro Sampling Devices: Distribution by Type of Technology
Figure 4.5 At-Home Blood Collection and Micro Sampling Devices: Distribution by Device Usage
Figure 4.6 At-Home Blood Collection and Micro Sampling Devices: Distribution by Type of Sample
Figure 4.7 At-Home Blood Collection and Micro Sampling Devices: Distribution by Blood Sample State
Figure 4.8 At-Home Blood Collection and Micro Sampling Devices: Distribution by Volume of Sample Collected
Figure 4.9 At-Home Blood Collection and Micro Sampling Devices: Distribution by Puncture Site
Figure 4.10 At-Home Blood Collection and Micro Sampling Devices: Distribution by Method of Sample Collection
Figure 4.11 At-Home Blood Collection and Micro Sampling Devices: Distribution by Storage Temperature
Figure 4.12 At-Home Blood Collection and Micro Sampling Devices: Distribution by Application Area
Figure 4.13 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Year of Establishment
Figure 4.14 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Company Size
Figure 4.15 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Location of Headquarters (Continent-wise)
Figure 4.16 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Location of Headquarters (Country-wise)
Figure 4.17 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Year of Establishment, Company Size and Location of Headquarters
Figure 4.18 Most Active Players: Distribution by Number of Products
Figure 4.19 Most Active Players: Distribution by Current Status of Development
Figure 5.1 Product Competitiveness Analysis: North America Scenario
Figure 5.2 Product Competitiveness Analysis: Europe Scenario
Figure 5.3 Product Competitiveness Analysis: Asia-Pacific Scenario
Figure 7.1 Patent Analysis: Distribution by Type of Patent
Figure 7.2 Patent Analysis: Cumulative Distribution by Publication Year, 2015-2021
Figure 7.3 Patent Analysis: Distribution by Type of Patent and Publication Year
Figure 7.4 Patent Analysis: Distribution by Geography
Figure 7.5 Patent Analysis: North America Scenario
Figure 7.6 Patent Analysis: Asia-Pacific Scenario
Figure 7.7 Patent Analysis: Distribution by CPC Symbols
Figure 7.8 Patent Analysis: Distribution by Emerging Focus Area
Figure 7.9 Most Active Players: Distribution by Number of Patents
Figure 7.10 Patent Benchmarking Analysis: YourBio Health and Becton Dickinson
Figure 7.11 Patent Benchmarking Analysis: Other Leading Players
Figure 7.12 Patent Portfolio: Distribution by Patent Age
Figure 7.13 Patent Valuation Analysis
Figure 7.14 Overall Intellectual Property Portfolio: Distribution by Type of Organization
Figure 8.1 Partnerships: Cumulative Year-wise Trend, 2016-2021
Figure 8.2 Partnerships: Distribution by Type of Partnership
Figure 8.3 Partnerships: Distribution by Year and Type of Partnership
Figure 8.4 Partnerships: Distribution by Focus Area
Figure 8.5 Partnerships: Distribution by Year of Partnership and Focus Area
Figure 8.6 Heat Map: Distribution by Type of Partnership and Focus Area
Figure 8.7 Partnerships: Distribution by Therapeutic Area
Figure 8.8 Partnerships: Continent-wise Distribution
Figure 8.9 Partnerships: Intercontinental and Intracontinental Agreements
Figure 8.10 Partnerships: Country-wise Distribution
Figure 8.11 Most Active Players: Distribution by Number of Partnerships
Figure 9.1 Funding and Investment Analysis: Cumulative Year-wise Distribution of Number of Instances, 2013-2021
Figure 9.2 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, 2013-2021 (USD Million)
Figure 9.3 Funding and Investment Analysis: Distribution by Type of Funding, 2013-2021
Figure 9.4 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding, 2013-2021 (USD Million)
Figure 9.5 Funding and Investment Analysis: Distribution by Year and Type of Funding, 2013-2021
Figure 9.6 Funding and Investment Analysis: Distribution by Year, Type of Funding and Amount Invested, 2013-2021 (USD Million)
Figure 9.7 Funding and Investment Analysis: Summary of Investments, 2013-2021 (USD Million)
Figure 9.8 Funding and Investment Analysis: Distribution by Geography
Figure 9.9 Funding and Investment Analysis: Regional Distribution of Funding Instances
Figure 9.10 Most Active Players: Distribution by Number of Funding Instances
Figure 9.11 Most Active Players: Distribution by Amount Invested
Figure 9.12 Funding and Investment Analysis: Distribution by Type of Investor
Figure 9.13 Key Investors: Distribution by Number of Funding Instances
Figure 9.14 Funding and Investment Analysis: Distribution by Purpose of Investment
Figure 9.15 Funding and Investment Analysis: Distribution by Application Area
Figure 10.1 Overall Cost Saving Potential of At-Home Blood Collection and Micro Sampling Devices, 2021-2030 (USD Million)
Figure 11.1 Global At-Home Blood Collection and Micro Sampling Device Market, 2021-2030 (USD Million)
Figure 11.2 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Blood Sample State, 2021-2030 (USD Million)
Figure 11.3 At-Home Blood Collection and Micro Sampling Device Market for Dried Blood Samples, 2021-2030 (USD Million)
Figure 11.4 At-Home Blood Collection and Micro Sampling Device Market for Liquid Blood Samples, 2021-2030 (USD Million)
Figure 11.5 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Method of Sample Collection, 2021-2030 (USD Million)
Figure 11.6 At-Home Blood Collection and Micro Sampling Device Market for Fingerstick Method of Sample Collection, 2021-2030 (USD Million)
Figure 11.7 At-Home Blood Collection and Micro Sampling Device Market for Push-Button Method of Sample Collection, 2021-2030 (USD Million)
Figure 11.8 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Device Usage, 2021-2030 (USD Million)
Figure 11.9 At-Home Blood Collection and Micro Sampling Device Market for Single-use Devices, 2021-2030 (USD Million)
Figure 11.10 At-Home Blood Collection and Micro Sampling Device Market for Reusable Devices, 2021-2030 (USD Million)
Figure 11.11 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Areas of Application, 2021-2030 (USD Million)
Figure 11.12 At-Home Blood Collection and Micro Sampling Device Market for Diagnostic Purposes, 2021-2030 (USD Million)
Figure 11.13 At-Home Blood Collection and Micro Sampling Device Market for Research Purposes, 2021-2030 (USD Million)
Figure 11.14 At-Home Blood Collection and Micro Sampling Device Market for Therapeutic Purposes, 2021-2030 (USD Million)
Figure 11.15 At-Home Blood Collection and Micro Sampling Device Market for Other Areas of Application, 2021-2030 (USD Million)
Figure 11.16 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Region, 2021-2030 (USD Million)
Figure 11.17 At-Home Blood Collection and Micro Sampling Device Market in North America, 2021-2030 (USD Million)
Figure 11.18 At-Home Blood Collection and Micro Sampling Device Market in Europe, 2021-2030 (USD Million)
Figure 11.19 At-Home Blood Collection and Micro Sampling Device Market in Asia-Pacific, 2021-2030 (USD Million)
Figure 11.20 At-Home Blood Collection and Micro Sampling Device Market in Latin America, 2021-2030 (USD Million)
Figure 11.21 At-Home Blood Collection and Micro Sampling Device Market in MENA, 2021-2030 (USD Million)
Figure 12.1 Concluding Remarks: Current Market Landscape
Figure 12.2 Concluding Remarks: Product Competitiveness Analysis
Figure 12.3 Concluding Remarks: Patent Analysis
Figure 12.4 Concluding Remarks: Partnerships and Collaborations
Figure 12.5 Concluding Remarks: Funding and Investment Analysis
Figure 12.6 Concluding Remarks: Market Sizing and Opportunity Analysis
List Of Tables
Table 3.1 Various Applications of Complete Blood Count Test
Table 3.2 Various Applications of Basic Metabolic Panel
Table 3.3 Various Applications of Lipoprotein Panel
Table 4.1 At-Home Blood Collection and Micro Sampling Devices: Current Market Landscape
Table 4.2 At-Home Blood Collection and Micro Sampling Devices: Information on Devices
Table 4.3 At-Home Blood Collection and Micro Sampling Devices: Information on Samples Collected
Table 4.4 At-Home Blood Collection and Micro Sampling Devices: Information on Type of Technology and Application Area
Table 4.5 At-Home Blood Collection and Micro Sampling Devices: List of Developers
Table 6.1 EUROIMMUN: Company Overview
Table 6.2 EUROIMMUN: Product Portfolio
Table 6.3 Everlywell: Company Overview
Table 6.4 Everlywell: Product Portfolio
Table 6.5 Everlywell: Recent Developments and Future Outlook
Table 6.6 Labcorp: Company Overview
Table 6.7 Labcorp: Product Portfolio
Table 6.8 Labonovum: Company Overview
Table 6.9 Labonovum: Product Portfolio
Table 6.10 Lameditech: Company Overview
Table 6.11 Lameditech: Product Portfolio
Table 6.12 Quest Diagnostics: Company Overview
Table 6.13 Quest Diagnostics: Product Portfolio
Table 6.14 Spot On Sciences: Company Overview
Table 6.15 Spot On Sciences: Product Portfolio
Table 6.16 Spot On Science: Recent Developments and Future Outlook
Table 6.17 Tasso: Company Overview
Table 6.18 Tasso: Product Portfolio
Table 6.19 Tasso: Recent Developments and Future Outlook
Table 6.20 Weavr Health: Company Overview
Table 6.21 Weavr Health: Product Portfolio
Table 6.22 Weavr Health: Recent Developments and Future Outlook
Table 6.23 YourBio Health: Company Overview
Table 6.24 YourBio Health: Product Portfolio
Table 7.1 Patent Analysis: List of Top CPC Symbols
Table 7.2 Patent Analysis: Summary of Benchmarking Analysis
Table 7.3 Patent Analysis: Various Categorizations based on Weighted Valuation Scores
Table 7.4 Patent Analysis: List of Leading Patents (In Terms of Highest Relative Valuation)
Table 8.1 At-Home Blood Collection and Micro Sampling Devices: List of Partnerships
Table 8.2 Partnerships: Information on Focus Area and Therapeutic Area
Table 9.1 At-Home Blood Collection and Micro Sampling Device Market: Funding and Investments, 2013-2021
Table 9.2 Funding and Investment Analysis: Summary of Investments
Table 9.3 Funding and Investment Analysis: Summary of Venture Capital Funding
Table 9.4 At-Home Blood Collection and Micro Sampling Device Market: Information on Purpose of Funding and Area of Application, 2013-2021
Table 14.1 At-Home Blood Collection and Micro Sampling Devices: Distribution by Device Class
Table 14.2 At-Home Blood Collection and Micro Sampling Devices: Distribution by Current Status of Development
Table 14.3 At-Home Blood Collection and Micro Sampling Devices: Distribution by Regulatory Approvals / Certifications Received
Table 14.4 At-Home Blood Collection and Micro Sampling Devices: Distribution by Type of Technology
Table 14.5 At-Home Blood Collection and Micro Sampling Devices: Distribution by Device Usage
Table 14.6 At-Home Blood Collection and Micro Sampling Devices: Distribution by Type of Sample
Table 14.7 At-Home Blood Collection and Micro Sampling Devices: Distribution by Blood Sample State
Table 14.8 At-Home Blood Collection and Micro Sampling Devices: Distribution by Volume of Sample Collected
Table 14.9 At-Home Blood Collection and Micro Sampling Devices: Distribution by Puncture Site
Table 14.10 At-Home Blood Collection and Micro Sampling Devices: Distribution by Method of Sample Collection
Table 14.11 At-Home Blood Collection and Micro Sampling Devices: Distribution by Storage Temperature
Table 14.12 At-Home Blood Collection and Micro Sampling Devices: Distribution by Application Area
Table 14.13 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Year of Establishment
Table 14.14 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Company Size
Table 14.15 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Location of Headquarters (Continent-wise)
Table 14.16 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Location of Headquarters (Country-wise)
Table 14.17 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Year of Establishment, Company Size and Location of Headquarters
Table 14.18 Most Active Players: Distribution by Number of Products
Table 14.19 Most Active Players: Distribution by Current Status of Development
Table 14.20 Patent Analysis: Distribution by Type of Patent
Table 14.21 Patent Analysis: Cumulative Distribution by Publication Year, 2015-2021
Table 14.22 Patent Analysis: Distribution by Type of Patent and Publication Year
Table 14.23 Patent Analysis: Distribution by Geography
Table 14.24 Patent Analysis: North America Scenario
Table 14.25 Patent Analysis: Asia-Pacific Scenario
Table 14.26 Most Active Players: Distribution by Number of Patents
Table 14.27 Patent Analysis: Distribution by Patent Age
Table 14.28 Overall Intellectual Property Portfolio: Distribution by Type of Organization
Table 14.29 Partnerships: Cumulative Year-wise Trend, 2016-2021
Table 14.30 Partnerships: Distribution by Type of Partnership
Table 14.31 Partnerships: Distribution by Year and Type of Partnership
Table 14.32 Partnerships: Distribution by Focus Area
Table 14.33 Partnerships: Distribution by Type of Partnership and Focus Area
Table 14.34 Partnerships: Distribution by Therapeutic Area
Table 14.35 Partnerships: Continent-wise Distribution
Table 14.36 Partnerships: Country-wise Distribution
Table 14.37 Most Active Players: Distribution by Number of Partnerships
Table 14.38 Funding and Investment Analysis: Cumulative Year-wise Distribution of Number of Instances, 2013-2021
Table 14.39 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, 2013-2021 (USD Million)
Table 14.40 Funding and Investment Analysis: Distribution by Type of Funding, 2013-2021
Table 14.41 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding, 2013-2021 (USD Million)
Table 14.42 Funding and Investment Analysis: Distribution by Year and Type of Funding, 2013-2021
Table 14.43 Funding and Investment Analysis: Summary of Investments, 2013-2021 (USD Million)
Table 14.44 Funding and Investment Analysis: Distribution by Geography
Table 14.45 Funding and Investment Analysis: Regional Distribution of Funding Instances
Table 14.46 Most Active Players: Distribution by Number of Funding Instances
Table 14.47 Most Active Players: Distribution by Amount Invested
Table 14.48 Funding and Investment Analysis: Distribution by Type of Investor
Table 14.49 Key Investors: Distribution by Number of Funding Instances
Table 14.50 Funding and Investment Analysis: Distribution by Purpose of Investment
Table 14.51 Funding and Investment Analysis: Distribution by Application Area
Table 14.52 Overall Cost Saving Potential of At-Home Blood Collection and Micro Sampling Devices, 2021-2030 (USD Million)
Table 14.53 Global At-Home Blood Collection and Micro Sampling Device Market, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 14.54 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Blood Sample State, 2021-2030 (USD Million)
Table 14.55 At-Home Blood Collection and Micro Sampling Device Market for Dried Blood Samples, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 14.56 At-Home Blood Collection and Micro Sampling Device Market for Liquid Blood Samples, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 14.57 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Method of Sample Collection, 2021-2030 (USD Million)
Table 14.58 At-Home Blood Collection and Micro Sampling Device Market for Fingerstick Method of Sample Collection, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 14.59 At-Home Blood Collection and Micro Sampling Device Market for Push-Button Method of Sample Collection, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 14.60 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Device Usage, 2021-2030 (USD Million)
Table 14.61 At-Home Blood Collection and Micro Sampling Device Market for Single-use Devices, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 14.62 At-Home Blood Collection and Micro Sampling Device Market for Reusable Devices, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 14.63 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Areas of Application, 2021-2030 (USD Million)
Table 14.64 At-Home Blood Collection and Micro Sampling Device Market for Diagnostics Purposes, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 14.65 At-Home Blood Collection and Micro Sampling Device Market for Research Purposes, Conservative, Base and Optimistic Scenarios, 2021-2030 (USD Million)
Table 14.66 At-Home Blood Collection and Micro Sampling Device Market for Therapeutics Purposes, Conservative, Base and Optimistic Scenarios, 2021-2030 (USD Million)
Table 14.67 At-Home Blood Collection and Micro Sampling Device Market for Other Areas of Application, Conservative, Base and Optimistic Scenarios, 2021-2030 (USD Million)
Table 14.68 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Region, 2021-2030 (USD Million)
Table 14.69 At-Home Blood Collection and Micro Sampling Device Market in North America, Conservative, Base and Optimistic Scenarios, 2021-2030 (USD Million)
Table 14.70 At-Home Blood Collection and Micro Sampling Device Market in Europe, Conservative, Base and Optimistic Scenarios, 2021-2030 (USD Million)
Table 14.71 At-Home Blood Collection and Micro Sampling Device Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2021-2030 (USD Million)
Table 14.72 At-Home Blood Collection and Micro Sampling Device Market in Latin America, Conservative, Base and Optimistic Scenarios, 2021-2030 (USD Million)
Table 14.73 At-Home Blood Collection and Micro Sampling Device Market in MENA, Conservative, Base and Optimistic Scenarios, 2021-2030 (USD Million)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alliance Global Group
- Anzu Partners
- Appian
- ARCHIMEDlife
- Astia
- Avis Budget Group
- Bill & Melinda Gates Foundation
- BlackRock
- BloodTrackR
- Brechbühler
- Brown University
- Business Oregon
- Capitainer
- Capitala
- Cedars-Sinai
- Cerba HealthCare
- City of Hope
- Comcast Ventures
- DBS System
- Defense Advanced Research Projects Agency
- Defense Threat Reduction Agency
- Development Bank of Wales
- diaago
- DoorDash
- DxTerity
- Eastern Business Forms
- EUROIMMUN
- Everlywell
- Fast Track to Innovation
- Flagship Pioneering
- Floragenex
- Foresite Capital
- Forth & Forth Edge
- Foundation for Technological Innovation
- Gen Cap America
- Goodwater Capital
- Greenspring Associates (acquired by StepStone Group)
- Guinness Asset Management
- Hambrecht Ducera Growth Ventures
- Highland Capital Partners
- Home Access Health
- Ionis Pharmaceuticals
- J. Hunt Holdings
- Kleiner Perkins
- Lab Me Analytics
- Labcorp
- Labonovum
- Lameditech
- Lipomic Healthcare
- LiveSmart
- Lloyd & Whyte
- Loop Medical
- Lux Capital
- Mawi DNA Technologies
- Miraca Holdings
- Molecular Testing Labs
- Morningside
- myGP
- MyHealthTest
- National Institute of Health
- Neoteryx
- NextGen Venture Partners
- Nightingale Health
- Nordic Consumer Health
- Novartis
- Novilytic
- Nucleus Biotech
- Nurx
- PanoHealth
- Pembroke VCT
- Perci Health
- Pike Street Capital
- Polaris Partners
- Portfolia
- Public Health Solutions
- PWNHealth
- Q2 Solutions
- Quest Diagnostics
- Ro
- Sandstone Diagnostics
- Sciety
- Sedia Biosciences
- Sengenics (acquired by Summa Equity)
- Seventh Sense Biosystems
- Siemens
- Simplexity Product Development
- Soltec
- Spot On Sciences
- SWK Holdings
- Symbiotica
- Target Global
- Tasso
- The Chernin Group
- The Doctors Laboratory
- Thriva
- Trajan Scientific and Medical
- Tribeca Companies
- Trustbridge Partners
- Union Square Ventures
- University of North Texas
- US BioTek Laboratories
- VCI Partners
- Versus Arthritis
- Vertical Venture Partners
- Verve Ventures
- Weavr Health
- Wittington Ventures
- Wolf Family Trust
- Y Combinator
- ZRT Laboratory
Methodology
LOADING...
